Colland F - Search Results

1

Targeting ubiquitin specific proteases for drug discovery.

Daviet L, Colland F. Daviet L, et al. Among authors: colland f. Biochimie. 2008 Feb;90(2):270-83. doi: 10.1016/j.biochi.2007.09.013. Epub 2007 Sep 22. Biochimie. 2008. PMID: 17961905 Review.

2

Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase.

Cholay M, Reverdy C, Benarous R, Colland F, Daviet L. Cholay M, et al. Among authors: colland f. Exp Cell Res. 2010 Feb 15;316(4):667-75. doi: 10.1016/j.yexcr.2009.10.023. Epub 2009 Nov 10. Exp Cell Res. 2010. PMID: 19909739

3

Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.

Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, Trouplin V, Bianchi J, Aushev VN, Camonis J, Calabrese A, Borg-Capra C, Sippl W, Collura V, Boissy G, Rain JC, Guedat P, Delansorne R, Daviet L. Colland F, et al. Mol Cancer Ther. 2009 Aug;8(8):2286-95. doi: 10.1158/1535-7163.MCT-09-0097. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671755

4

Combination of active and inactive siRNA targeting the mitotic kinesin Eg5 impairs silencing efficiency in several cancer cell lines.

Formstecher E, Reverdy C, Cholay M, Planquette C, Trouplin V, Lehrmann H, Aresta S, Calabrese A, Arar K, Daviet L, Colland F. Formstecher E, et al. Among authors: colland f. Oligonucleotides. 2006 Winter;16(4):387-94. doi: 10.1089/oli.2006.16.387. Oligonucleotides. 2006. PMID: 17155913

5

Ubiquitin and cancer: from molecular targets and mechanisms to the clinic -- AACR Special Conference.

Colland F. Colland F. IDrugs. 2006 Mar;9(3):179-81. IDrugs. 2006. PMID: 16523381 No abstract available.

6

Integrating a functional proteomic approach into the target discovery process.

Colland F, Daviet L. Colland F, et al. Biochimie. 2004 Sep-Oct;86(9-10):625-32. doi: 10.1016/j.biochi.2004.09.014. Biochimie. 2004. PMID: 15556272 Review.

7

The therapeutic potential of deubiquitinating enzyme inhibitors.

Colland F. Colland F. Biochem Soc Trans. 2010 Feb;38(Pt 1):137-43. doi: 10.1042/BST0380137. Biochem Soc Trans. 2010. PMID: 20074048 Review.

8

Patented small molecule inhibitors in the ubiquitin proteasome system.

Guédat P, Colland F. Guédat P, et al. Among authors: colland f. BMC Biochem. 2007 Nov 22;8 Suppl 1(Suppl 1):S14. doi: 10.1186/1471-2091-8-S1-S14. BMC Biochem. 2007. PMID: 18047738 Free PMC article. Review.

9

Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.

Reverdy C, Conrath S, Lopez R, Planquette C, Atmanene C, Collura V, Harpon J, Battaglia V, Vivat V, Sippl W, Colland F. Reverdy C, et al. Among authors: colland f. Chem Biol. 2012 Apr 20;19(4):467-77. doi: 10.1016/j.chembiol.2012.02.007. Chem Biol. 2012. PMID: 22520753

10

Ubiquitin-specific proteases as cancer drug targets.

Sippl W, Collura V, Colland F. Sippl W, et al. Among authors: colland f. Future Oncol. 2011 May;7(5):619-32. doi: 10.2217/fon.11.39. Future Oncol. 2011. PMID: 21568678 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results